Tukysa Európska únia - slovenčina - EMA (European Medicines Agency)

tukysa

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastické činidlá - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

Adolax 40 mg/20 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

adolax 40 mg/20 mg

krka, d.d., novo mesto, slovinsko - oxykodón a naloxón - 65 - analgetica - anodyna

Adolax 20 mg/10 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

adolax 20 mg/10 mg

krka, d.d., novo mesto, slovinsko - oxykodón a naloxón - 65 - analgetica - anodyna

Adolax 10 mg/5 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

adolax 10 mg/5 mg

krka, d.d., novo mesto, slovinsko - oxykodón a naloxón - 65 - analgetica - anodyna